Verve Therapeutics (VERV) Insider Trading & Ownership $5.09 -0.52 (-9.27%) (As of 05:44 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Verve Therapeutics (NASDAQ:VERV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$475,760.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$12,475.36 Get VERV Insider Trade Alerts Want to know when executives and insiders are buying or selling Verve Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VERV Insider Buying and Selling by Quarter Ad Porter & CompanyU.S. Government: “this could save civilization.”Experts indicate that ChatGPT alone consumes up to 17,000 times more electricity than the average U.S. household uses in a single day. And with companies like Google and Microsoft implementing AI into everything we do, that energy consumption is only going to exponentially increase. Thing is, outside of a small group of elite investors, nobody has connected the dots on how this military contractor could be the most important company in the AI boom.To get all the details, go here now. Verve Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/14/2024Andrew D AsheInsiderBuy76,000$6.26$475,760.00 4/2/2024Joan NickersonInsiderSell1,514$8.24$12,475.36 (Data available from 1/1/2013 forward) VERV Insider Trading Activity - Frequently Asked Questions Who is on Verve Therapeutics's Insider Roster? The list of insiders at Verve Therapeutics includes 2017 Gp L.L.C. Gv, Allison Dorval, Andrew Bellinger, Andrew D Ashe, Burt A Adelman, Fmr Llc, Joan Nickerson, Krishna Yeshwant, and Sekar Kathiresan. Learn more on insiders at VERV. What percentage of Verve Therapeutics stock is owned by insiders? 19.30% of Verve Therapeutics stock is owned by insiders. Learn more on VERV's insider holdings. Which Verve Therapeutics insiders have been buying company stock? The following insider purchased VERV shares in the last 24 months: Andrew D Ashe ($475,760.00). How much insider buying is happening at Verve Therapeutics? Insiders have purchased a total of 76,000 VERV shares in the last 24 months for a total of $475,760.00 bought. Which Verve Therapeutics insiders have been selling company stock? The following insiders have sold VERV shares in the last 24 months: Allison Dorval ($6,343.30), and Joan Nickerson ($12,475.36). How much insider selling is happening at Verve Therapeutics? Insiders have sold a total of 2,068 Verve Therapeutics shares in the last 24 months for a total of $18,818.66 sold. Verve Therapeutics Key ExecutivesDr. Sekar Kathiresan M.D. (Age 51)Co-Founder, CEO & Director Compensation: $973.25kMs. Allison Dorval (Age 48)CFO & Principal Accounting Officer Compensation: $711.76kDr. Andrew M. Bellinger M.D. (Age 46)Ph.D., Chief Scientific Officer Compensation: $758.29kMr. Andrew D. Ashe J.D. (Age 57)President, COO & General Counsel Compensation: $703.85kDr. Kiran Musunuru M.D.M.P.H., Ph.D., Co-FounderDr. J. Keith Joung M.D.Ph.D., Co-FounderDr. Anthony Philippakis M.D.Ph.D., Co-Founder & Scientific Advisory Board MemberDr. Barry S. Ticho FACC (Age 63)M.D., Ph.D., Co-Founder Mr. Issi Rozen M.B.A.Co-Founder & Strategic AdvisorMs. Joan Nickerson M.B.A. (Age 55)Chief Administrative Officer More Insider Trading Tools from MarketBeat Related Companies Xencor Insider Trading Arcutis Biotherapeutics Insider Trading Nurix Therapeutics Insider Trading Arcus Biosciences Insider Trading Kiniksa Pharmaceuticals Insider Trading Immunocore Insider Trading Ocular Therapeutix Insider Trading Travere Therapeutics Insider Trading Intellia Therapeutics Insider Trading Praxis Precision Medicines Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:VERV) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERV Stock Alerts